GlassScriptPhysician profile
George John Arcos
NPI 1255432878
$30,459.72
in general payments reported to CMS, 2019-2025
30 companies · $1,307 in 2025
The $1,307 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $11K · 2021: $186 · 2022: $1,200 · 2023: $2,145 · 2024: $639 · 2025: $1,307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,614 · Travel and Lodging: $1,477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,614.36 |
| Travel and Lodging | $1,477.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $23,364.94 | 2019-2020 | |
| Boston Scientific Corporation | $2,184.88 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, Na |
| Spinal Simplicity, LLC | $1,709.89 | 2023-2024 | Ha Minuteman G3-R |
| Relievant Medsystems, INC. | $1,281.41 | 2019-2022 | |
| Vgi Medical, LLC | $628.51 | 2022 | |
| Painteq LLC | $145.35 | 2023-2024 | Painteq |
| Collegium Pharmaceutical, INC. | $134.30 | 2022-2025 | Xtampza, Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $128.46 | 2024-2025 | Relistor |
| Spinefrontier, INC. | $121.44 | 2025 | Inspan, Facetfuse, Nanofuse |
| Alphatec Spine, INC | $111.72 | 2021 | |
| Spr Therapeutics, INC | $103.56 | 2023-2025 | Sprint Pns System |
| Nevro Corp. | $66.78 | 2023-2024 | Senza |
| Forte Bio-Pharma LLC | $55.31 | 2024-2025 | Prolate, Nalocet, Tanlor |
| Medtronic, INC. | $51.91 | 2022-2024 | Intellis Adaptivestim |
| Abbott Laboratories | $48.07 | 2019-2024 | Eterna |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $43.43 | 2020 | |
| Vertos Medical, INC. | $36.85 | 2024 | Mild Device Kit |
| Indivior INC. | $29.55 | 2024 | Sublocade |
| Grt US Holding, INC. | $22.74 | 2021 | |
| Ibsa Pharma INC. | $22.31 | 2023 | Tirosint, Licart |
| Protega Pharmaceutials INC | $22.15 | 2023 | Roxybond |
| Abbvie INC. | $20.73 | 2024 | |
| Alnylam Pharmaceuticals INC. | $19.92 | 2024 | Givlaari |
| Almatica Pharma LLC | $16.60 | 2022 | |
| Pfizer INC. | $16.05 | 2019 | |
| Medline Industries LP | $15.72 | 2023 | |
| Idorsia Pharmaceuticals US INC | $15.55 | 2023 | Quviviq |
| Si-Bone, INC. | $15.35 | 2024 | |
| Fidia Pharma USA INC. | $14.20 | 2024 | Hym/Hyn |
| Glaxosmithkline, LLC. | $12.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Arcos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.